The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
The gut microbiome as a target for IBD treatment: are we there yet
Abstract
Purpose of review This review aims to highlight recent research on the gut microbiome in IBD and the application of microbiome-modulating therapies for the treatment of IBD including the use of the microbiome as an indicator for disease severity and treatment response. Recent findings Despite the high number of gut microbiome studies and emerging evidence supporting the gut microbiome's involvement in disease pathogenesis, no single microorganism has been identified as a pathogenic agent in IBD. Retrospective studies and meta-analyses on antibiotic use in ulcerative colitis and Crohn's disease and long-term outcomes are conflicting. Similarly, the use of probiotics for the treatment of IBD remains inconclusive; however, some encouraging results are emerging as microbial concoctions are optimized to include beneficial bacterial strains. Fecal microbial transplantation (FMT) is currently emerging as one of the more promising microbiome-modulating IBD therapies. FMT studies in ulcerative colitis have shown improved remission rates compared to placebo; however, relatively small study sample sizes and varied treatment methods, limit definitive conclusions. With clear evidence of an IBD gut dysbiosis, novel therapies to treat and prevent disease relapse will undoubtedly require a microbiome-modulating approach. The complexity and variability of IBD disease pathogenesis (disease phenotype, gut microbiome, host genetic susceptibility, and environmental factors) will likely require a personalized and multidimensional treatment approach where microbiome-modulating therapy is coupled with other therapies to target other IBD disease components.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220
Environment dominates over host genetics in shaping human gut microbiota
Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., Costea, P. I., Godneva, A., Kalka, I. N., Bar, N., et al. (2018) · Nature · doi:10.1038/nature25973 · Cited by 2,859
Dethlefsen, L., & Relman, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000087107 · Cited by 2,421
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Immunopathogenesis of IBD: current state of the art
de Souza, H. S. P., & Fiocchi, C. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.186 · Cited by 1,551
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Fungal microbiota dysbiosis in IBD
Sokol, H., Leducq, V., Aschard, H., Pham, H., Jégou, S., Landman, C., Cohen, D., Liguori, G., Bourrier, A., Nion–Larmurier, I., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310746 · Cited by 1,382
Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
Norman, J. M., Handley, S. A., Baldridge, M. T., Droit, L., Liu, C. Y., Keller, B. C., Kambal, A., Monaco, C. L., Zhao, G., Fleshner, P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.002 · Cited by 1,285
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276
Cited by
Sorted by citations
Items 101–119 of 119
Wang, X., Yang, Y., Li, J., Jiang, R., Chen, T., & Zhu, C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.14.426764 · Cited by 1
Integrative medicine in allergy and immunology
Zhong, L. L., Lam, W. C., Cheung, H. L. H., & Lü, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95061-9.00047-3
Association of Primate Veterinarians Guidelines for the Management of Diarrhea.
(2023) · PubMed Central
Veseli, I., Chen, Y. T., Schechter, M. S., et al. (2023) · eLife · doi:10.7554/elife.89862.1.sa1
Methodology for Biomarker Discovery with Reproducibility in Microbiome Data using Machine LearningPreprint
Rojas-Velázquez, D., Kidwai, S., Kraneveld, A. D., Tonda, A. P., Oberski, D. L., Garssen, J., & Lopez‐Rincon, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3699085/v1
Rojas-Velázquez, D., Kidwai, S., Kraneveld, A. D., Tonda, A. P., Oberski, D. L., Garssen, J., & Lopez‐Rincon, A. (2024) · Figshare · doi:10.6084/m9.figshare.25001638
34. Microbiota Intestinal: noções de análise e relações com doenças
de Moraes, A. C. F., & Vívolo, S. R. G. F. (2024) · Editora FIOCRUZ eBooks · doi:10.7476/9786557081891.0037
Xu, X., Ocansey, D. K. W., Hang, S., Wang, B., Amoah, S., Yi, C., Zhang, X., Liu, L., & Mao, F. (2022) · Figshare · doi:10.6084/m9.figshare.20115656
Xu, X., Ocansey, D. K. W., Hang, S., Wang, B., Amoah, S., Yi, C., Zhang, X., Liu, L., & Mao, F. (2022) · Figshare · doi:10.6084/m9.figshare.20115653
Rojas-Velázquez, D., Kidwai, S., Kraneveld, A. D., Tonda, A. P., Oberski, D. L., Garssen, J., & Lopez‐Rincon, A. (2024) · Figshare · doi:10.6084/m9.figshare.26667900
Hanscom, M., Loane, D. J., Aubretch, T., Leser, J. M., Molesworth, K., Hedgekar, N., Ritzel, R. M., Abulwerdi, G., Shea‐Donohue, T., & Faden, A. I. (2021) · Figshare · doi:10.6084/m9.figshare.13605619
Hanscom, M., Loane, D. J., Aubretch, T., Leser, J. M., Molesworth, K., Hedgekar, N., Ritzel, R. M., Abulwerdi, G., Shea‐Donohue, T., & Faden, A. I. (2021) · Figshare · doi:10.6084/m9.figshare.13605625
Rojas-Velázquez, D., Kidwai, S., Kraneveld, A. D., Tonda, A. P., Oberski, D. L., Garssen, J., & Lopez‐Rincon, A. (2024) · Figshare · doi:10.6084/m9.figshare.25001746
Hanscom, M., Loane, D. J., Aubretch, T., Leser, J. M., Molesworth, K., Hedgekar, N., Ritzel, R. M., Abulwerdi, G., Shea‐Donohue, T., & Faden, A. I. (2021) · Figshare · doi:10.6084/m9.figshare.13605622
Hanscom, M., Loane, D. J., Aubretch, T., Leser, J. M., Molesworth, K., Hedgekar, N., Ritzel, R. M., Abulwerdi, G., Shea‐Donohue, T., & Faden, A. I. (2021) · Figshare · doi:10.6084/m9.figshare.13605610
Hanscom, M., Loane, D. J., Aubretch, T., Leser, J. M., Molesworth, K., Hedgekar, N., Ritzel, R. M., Abulwerdi, G., Shea‐Donohue, T., & Faden, A. I. (2021) · Figshare · doi:10.6084/m9.figshare.13605616
Hanscom, M., Loane, D. J., Aubretch, T., Leser, J. M., Molesworth, K., Hedgekar, N., Ritzel, R. M., Abulwerdi, G., Shea‐Donohue, T., & Faden, A. I. (2021) · Figshare · doi:10.6084/m9.figshare.13605613
Hospital-Acquired Infections and the Challenge of Antimicrobial Resistance
Khan, M., Mubeen, H., & Nabi, I. G. (2026) · Infectious diseases · doi:10.5772/intechopen.1013611
Metadata
- Authors
- Knox, N. C., Forbes, J. D., Van Domselaar, G., & Bernstein, C. N.
- Affiliations
- Public Health Agency of Canada (CA)
- University of Toronto (CA)
- University of Manitoba (CA)
- Corresponding author
- Bernstein, Charles N.
- Venue
- Current Treatment Options in Gastroenterology
- Published
- 2019-01-19
- Volume
- 17
- Issue
- 1
- Pages
- 115-126
- ISSN
- 1092-8472 (ISSN-L)
- 1534-309X
- OpenAlex
- W2911082921
- Cited by
- 117
- References
- 54
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 10 · 2023: 19 · 2022: 19 · 2021: 28 · 2020: 22 · 2019: 11
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Treatment Options in Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- gut microbiota, inflammatory bowel disease, fecal microbiota transplantation, probiotics, antibiotic use, ulcerative colitis, Crohn's disease, gut dysbiosis, disease severity markers, treatment response, personalized medicine, relapse prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
